News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by CancerVAX, Inc
CancerVax Achieves Major Milestone in Activating Human Killer T-Cells Against Cancer
August 06, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review
July 28, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
July 14, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
June 15, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax to Target Colorectal Cancer Following Recent Biodistribution Breakthroughs
April 16, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
March 31, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
Biotech Veteran and Virologist Joins CancerVax as Senior Scientific Advisor
January 27, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
January 07, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Reviews Major Scientific and Strategic Milestones Achieved in 2025
December 23, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
December 17, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Precision Therapy Successfully Avoids Healthy Liver Cells
October 14, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
September 03, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Achieves Major Milestones and Files Foundational Patent Application
August 26, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Scientists Discuss the Recent CancerVax Breakthrough
August 19, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them
August 05, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
June 19, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
June 09, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle
June 05, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
June 03, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Top Biotech Exec Joins CancerVax as Chief Scientific Advisor
February 27, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Announces Successful Tests of its Smart mRNA Technology
February 25, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Passes First Test with Flying Colors
December 20, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Lands Top Cancer Expert
November 19, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
August 27, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Adds Key Members to Its Research Team
August 01, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
May 21, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
April 16, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Launches $5 Million Funding Round
April 03, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.